Technology Forum Series: Strategies to Prevent Drug Shortages and Resolve Capacity Challenges.

Register free: https://www.pharmtech.com/pt_w/forum

Event Overview:

A drug’s journey from development to manufacturing to patients is paved with roadblocks and potholes; many threats can derail bio/pharmaceutical processes. Potential solutions to such pitfalls have been discussed for years; however, few manufacturers have embraced technology and process advances to proactively ensure drug supply chain continuity.

The COVID-19 pandemic quickly brought supply chain and manufacturing deficiencies to light. The rapid deployment of select science- and technology-based solutions temporarily filled in productivity, communication, and supply chain gaps.

In this Technology Forum, the editors of Pharmaceutical Technology and BioPharm International share insight from process, manufacturing, and supply chain experts on promising and proven methods to ensure drug production continuity for small-molecule and biologic drugs.

10-11am EDT:

Reinventing Small-Molecule Drug Process Development and Manufacturing

The COVID-19 pandemic and nitrosamines contamination emergency exposed vulnerabilities in the small-molecule drug manufacturing and supply chain. Efforts to enhance continuous manufacturing processes, new technologies for process intensification, and investment in drug manufacturing infrastructure are showing promising results. Hear experts discuss current trends, and how technology and process improvements can advance the development, manufacturing, and distribution of generic and innovator small-molecule drug.

11am -1pm EDT:

Virtual Technology Forum Product Demos

1–2pm EDT:

Development and Manufacturing Strategies to Meet Biologic Drug Demand

Manufacturing capacity for biologic drugs, as well as fill-finish operations has been strained in the past year by demand for vaccines and therapies to combat COVID-19. Hear expert insight on how the bio/pharma industry is responding to the demand for materials, equipment, and manufacturing.

Key Learning Objectives:

• Understand strategies to for more efficient and effective small-molecule drug manufacturing
• Review regulatory implications of the pandemic and strategies to comply with GMPs
• Learn how demand for vaccines is impacting biologics drug manufacturing capacity, and ways to avoid roadblocks.

Time and Date:

Session 1: Thursday, April 22, 2021, 10am EDT

Session 2: Thursday, April 22, 2021, 11am EDT

Session 3: Thursday, April 22, 2021, 1pm EDT

Sponsor: Lonza, Emergent, Thermo Fisher Scientific, ILC Dover, Bora Pharmaceuticals, Patheon

Register free: https://www.pharmtech.com/pt_w/forum